Results 131 to 140 of about 7,902 (150)

Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care

Technical Innovations and Patient Support in Radiation Oncology
Stereotactic ablative body radiotherapy (SABR) is routinely used for the management of oligometastatic disease. Increasingly, there is overlap of targets or organs at risk with previous radiotherapy fields.
Kasia Owczarczyk, Elena Moreno-Olmedo, Peter Dickinson   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial

Radiotherapy and Oncology, 2023
Islam Mohamed, Andrew Bang, Howard Pai   +2 more
exaly  

A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study

Radiotherapy and Oncology, 2022
Luca Nicosia, Mattia Falchetto Osti, Andrei Fodor   +2 more
exaly  

A rough SABR formula

Frontiers of Mathematical Finance, 2022
Jim Gatheral, Masaaki Fukasawa
exaly  

Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm

Journal of Thoracic Oncology, 2017
Hilal Tekatli, Max Dahele, Wilko Verbakel   +2 more
exaly  

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review

Radiotherapy and Oncology, 2017
Ann Henry, David Sebag-Montefiore, Maria Andreia Hawkins   +2 more
exaly  

Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes

Radiotherapy and Oncology, 2015
Hilal Tekatli, Max Dahele, Wilko Verbakel   +2 more
exaly  

SABR for Baskets

Wilmott Magazine, 2021
exaly  

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

Annals of Oncology, 2013
Berend J Slotman, Suresh Senan, E F Smit   +2 more
exaly